News

Filter

1 to 9 of 17 results

EU5 rheumatologits rate Rituxan and Benlysta for Lupus

12-08-2013

Rheumatologists in the top European nations ( EU5) countries (France, Germany, Italy, Spain, UK) give…

Anti-Arthritics/RheumaticsBenlystaBiogen IdecBristol-Myers SquibbEuropeGlaxoSmithKlineMarkets & MarketingOrenciaPharmaceuticalRituxanRoche

NICE rejects second-line use of TNF-alpha drugs

28-07-2008

The National Institute for Health and Clinical Excellence (NICE), which advises the UK's National Health…

AbataceptAbbott LaboratoriesadalimumabAlphaAmgenBristol-Myers SquibbEnbreletanerceptHumirainfliximabJohnson & JohnsonOrenciaProlastinRemicadeRituxanrituximabRocheWyeth

Stock Commentary - New York week to May 5, 2008

12-05-2008

NEW YORK: equities moved in a narrow range on most of the five reporting days to May 5, with the...

Biogen IdecBristol-Myers SquibbConvaTecGenentechMerck KGaARituxanrituximab

"Condemned to a life of misery" by UK's NICE

05-05-2008

Rheumatoid arthritis patients "have [been] condemned to a life of misery," following a ruling by the…

AbataceptBristol-Myers SquibbEnbreletanerceptinfliximabOrenciaRemicadeRituxanrituximab

1 to 9 of 17 results

Back to top